BSE NSE
MARKET ANALYSIS NEWS CORPORATE INFORMATION CORPORATE ACTIONS OTHER MARKETS
Your Result on : Company News Details
ANG Lifesciences India Ltd Industry :  Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code
540694
ISIN Demat
INE236W01016
Book Value (Rs)
65.2573243
NSE Symbol
N.A
Divident Yield %
0
Market Cap
(Rs In Cr.)
74
P/E (TTM)
0
EPS (TTM)
0
Face Value
(Rs)
10
Back
ANG Lifesciences India reports consolidated net loss of Rs 2.32 crore in the September 2023 quarter
15-Nov-23   Hrs IST

Net loss of ANG Lifesciences India reported to Rs 2.32 crore in the quarter ended September 2023 as against net profit of Rs 2.63 crore during the previous quarter ended September 2022. Sales declined 44.40% to Rs 33.26 crore in the quarter ended September 2023 as against Rs 59.82 crore during the previous quarter ended September 2022.

ParticularsQuarter Ended
 Sep. 2023Sep. 2022% Var.
Sales33.2659.82 -44
OPM %4.9916.13 -
PBDT-0.416.50 PL
PBT-2.634.39 PL
NP-2.322.63 PL

Risk Factor   |   Terms & Conditions   |   Privacy Policy   |   Disclaimer   |  Sitemap 
Important Links:   SEBI   |   NSE   |   BSE   |   MCX   |   NCDEX   |   NSDL   |   CDSL  |   FMC
SMS FINANCIAL SERVICES P. LTD -NSE SEBI No. AP1413004363 | BSE SEBI No. AP01091801121968
2017-18 © SMS Financial Services. All rights reserved. Designed, developed & powered by C-MOTS Infotech (ISO 9001:2015 certified)